Shionogi Files Antiviral NDA In China, Eyes Wider Use

Competes with Pfizer's Paxlovid Upon Approval

 
• By Brian Yang
  
Doctor with Covid pill
SHIONOGI FILES CHINA NDA FOR ITS COVID PILL, EYES WIDER USE • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip